Single Cell RNA-Seq Identifies Cell Subpopulations Contributing to Idiopathic Pulmonary Fibrosis in Humans

Overview

Journal J Cell Mol Med

Date 2025 Feb 10

PMID 39928535

Authors

Tangjuan Zhang

ZhiChao Hou

Zheng Ding

Peng Wang

Xue Pan

Xiangnan Li

Affiliations

Soon will be listed here.

Abstract

The cell populations, particularly subpopulations, involved in the onset and progression of idiopathic pulmonary fibrosis (IPF) remain incompletely understood. This study employed single-cell RNA-seq to identify cell populations and subpopulations with significantly altered proportions in the lungs of patients with IPF. In IPF lungs, endothelial cell proportions were significantly increased, while alveolar epithelial cell proportions were markedly decreased. Among the three identified fibroblast subpopulations, the proportion of myofibroblasts was significantly increased, while the proportions of the other two fibroblast subtypes were reduced. Similarly, within the three macrophage subpopulations, the macrophage_SPP1 subpopulation, localised to fibroblastic foci, showed a significant increase in proportion, while the alveolar macrophage subpopulation was significantly reduced. Trajectory analysis revealed that fibroblasts in IPF lungs could differentiate into myofibroblasts, and alveolar macrophages could transition into the macrophage_SPP1 subpopulation. Among T-cell subpopulations, only the CD4 T_FOXP3 subpopulation exhibited a significant change, whereas all four B-cell subpopulations showed significant proportional shifts. These findings provide a comprehensive view of the cellular alterations contributing to IPF pathogenesis. Extensive interactions among various cell populations and subpopulations were identified. The proportions of various cell populations and subpopulations in IPF lungs, including endothelial cells, fibroblasts, macrophages and B cells, were significantly altered. Further in-depth investigation into the roles of cell subpopulations with significantly altered proportions in the onset and progression of IPF will provide valuable insights into the pathological mechanisms underlying the disease. This understanding could facilitate the development of novel therapeutic strategies and medications for IPF treatment.

References

Tsukui T, Sun K, Wetter J, Wilson-Kanamori J, Hazelwood L, Henderson N . Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat Commun. 2020; 11(1):1920. PMC: 7174390. DOI: 10.1038/s41467-020-15647-5. View

Nuovo G, Hagood J, Magro C, Chin N, Kapil R, Davis L . The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis. Mod Pathol. 2011; 25(3):416-33. PMC: 3270219. DOI: 10.1038/modpathol.2011.166. View

Hashimoto S, Gon Y, Takeshita I, Maruoka S, Horie T . IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway. J Allergy Clin Immunol. 2001; 107(6):1001-8. DOI: 10.1067/mai.2001.114702. View

Liao Y, Peng X, Yang Y, Zhou G, Chen L, Yang Y . Exploring ABHD5 as a Lipid-Related Biomarker in Idiopathic Pulmonary Fibrosis: Integrating Machine Learning, Bioinformatics, and In Vitro Experiments. Inflammation. 2024; . DOI: 10.1007/s10753-024-02107-1. View

Cosgrove G, Brown K, Schiemann W, Serls A, Parr J, Geraci M . Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med. 2004; 170(3):242-51. DOI: 10.1164/rccm.200308-1151OC. View

Raghu G, Chen S, Hou Q, Yeh W, Collard H . Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old. Eur Respir J. 2016; 48(1):179-86. DOI: 10.1183/13993003.01653-2015. View

Todd N, Luzina I, Atamas S . Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair. 2012; 5(1):11. PMC: 3443459. DOI: 10.1186/1755-1536-5-11. View

Moss B, Ryter S, Rosas I . Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. Annu Rev Pathol. 2021; 17:515-546. DOI: 10.1146/annurev-pathol-042320-030240. View

Lederer D, Martinez F . Idiopathic Pulmonary Fibrosis. N Engl J Med. 2018; 379(8):797-798. DOI: 10.1056/NEJMc1807508. View

10.

Ali M, Egan A, Shaughnessy G, Anderson D, Kottom T, Dasari H . Antifibrotics Modify B-Cell-induced Fibroblast Migration and Activation in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2021; 64(6):722-733. PMC: 8456878. DOI: 10.1165/rcmb.2020-0387OC. View

11.

Prele C, Miles T, Pearce D, ODonoghue R, Grainge C, Barrett L . Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis. Eur Respir J. 2022; 60(5). PMC: 9684624. DOI: 10.1183/13993003.01469-2021. View

12.

Liao Y, Yang Y, Zhou G, Chen L, Yang Y, Guo S . Anoikis and SPP1 in idiopathic pulmonary fibrosis: integrating bioinformatics, cell, and animal studies to explore prognostic biomarkers and PI3K/AKT signaling regulation. Expert Rev Clin Immunol. 2024; 20(6):679-693. DOI: 10.1080/1744666X.2024.2315218. View

13.

Kotsianidis I, Nakou E, Bouchliou I, Tzouvelekis A, Spanoudakis E, Steiropoulos P . Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009; 179(12):1121-30. DOI: 10.1164/rccm.200812-1936OC. View

14.

Vento-Tormo R, Efremova M, Botting R, Turco M, Vento-Tormo M, Meyer K . Single-cell reconstruction of the early maternal-fetal interface in humans. Nature. 2018; 563(7731):347-353. PMC: 7612850. DOI: 10.1038/s41586-018-0698-6. View

15.

Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner H . Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017; 14(10):979-982. PMC: 5764547. DOI: 10.1038/nmeth.4402. View

16.

Martinez F, Collard H, Pardo A, Raghu G, Richeldi L, Selman M . Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017; 3:17074. DOI: 10.1038/nrdp.2017.74. View

17.

Ley B, Collard H, King Jr T . Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010; 183(4):431-40. DOI: 10.1164/rccm.201006-0894CI. View

18.

Goodwin A, Noble P, Tatler A . Plasma cells: a feasible therapeutic target in pulmonary fibrosis?. Eur Respir J. 2022; 60(5). DOI: 10.1183/13993003.01748-2022. View

19.

Habermann A, Gutierrez A, Bui L, Yahn S, Winters N, Calvi C . Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci Adv. 2020; 6(28):eaba1972. PMC: 7439444. DOI: 10.1126/sciadv.aba1972. View

20.

Liao Y, Peng X, Yang Y, Zhou G, Chen L, Yang Y . Integrating cellular experiments, single-cell sequencing, and machine learning to identify endoplasmic reticulum stress biomarkers in idiopathic pulmonary fibrosis. Ann Med. 2024; 56(1):2409352. PMC: 11441044. DOI: 10.1080/07853890.2024.2409352. View